| Literature DB >> 29925726 |
Eiji Suzuki1, Takashi Kanno1, Satoru Kimura2, Takumi Irie3, Hajime Odajima4, Kiyoshi Migita5.
Abstract
Lymphoproliferative disorder (LPD) is a potentially severe adverse effect of methotrexate (MTX) administration in patients with rheumatoid arthritis (RA). We report a case of MTX-associated LPD (MTX-LPD) in a patient with RA who developed severe pulmonary failure complicated by perforation of the terminal ileum. A 61-year-old woman with RA receiving MTX complained of dyspnea and abdominal pain. She was diagnosed with intestinal perforation and peritonitis, and underwent immediate abdominal surgery. Pathological examinations of the specimen obtained from the resected ileum and a bone marrow aspirate revealed diffuse large B-cell lymphoma. Steroid therapy failed to improve her respiratory failure, but her condition improved after abdominal surgery and suspension of MTX. MTX-LPD can result in multiple life-threatening conditions; however, the symptoms are highly variable. RA patients receiving MTX should thus be monitored carefully, and MTX administration should be stopped immediately on suspicion of MTX-LPD.Entities:
Keywords: intestinal perforation; methotrexate; methotrexate-associated lymphoproliferative disorder; respiratory failure; rheumatoid arthritis
Mesh:
Substances:
Year: 2018 PMID: 29925726 PMCID: PMC6141454 DOI: 10.5387/fms.2017-23
Source DB: PubMed Journal: Fukushima J Med Sci ISSN: 0016-2590